Bridging Medical Specialities in the Management of Polycystic Ovary Syndrome: Integrating Lessons from Sodium-glucose Cotransporter-2 Inhibitors into a Holistic Approach.

Polycystic ovary syndrome presents significant metabolic, dermatologic and gynaecologic challenges, including hyperandrogenism, menstrual irregularities and obesity. While patients often consult different specialists for dermatologic or gynaecologic concerns, effective management requires placing metabolic health at the centre of all specialities involved; from endocrinology to nutrition. Traditional boundaries between specialities are fading, creating a more unified approach focused on metabolic management. This centralization fosters comprehensive strategies to address both immediate symptoms and long-term risks, leading to improved, holistic patient outcomes.